YorkBridge Wealth Partners, LLC - INMUNE BIO INC ownership

INMUNE BIO INC's ticker is INMB and the CUSIP is 45782T105. A total of 36 filers reported holding INMUNE BIO INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
YorkBridge Wealth Partners, LLC ownership history of INMUNE BIO INC
ValueSharesWeighting
Q4 2022$65,739
+2.7%
10,3690.0%0.02%0.0%
Q3 2022$64,000
-30.4%
10,3690.0%0.02%
-29.2%
Q2 2022$92,000
+5.7%
10,3690.0%0.02%
+26.3%
Q1 2022$87,000
-17.9%
10,3690.0%0.02%
-20.8%
Q4 2021$106,000
-47.3%
10,3690.0%0.02%
-52.9%
Q3 2021$201,000
+10.4%
10,3690.0%0.05%
+6.2%
Q2 2021$182,00010,3690.05%
Other shareholders
INMUNE BIO INC shareholders Q2 2022
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 275,000$5,341,0002.77%
Fermata Advisors, LLC 12,830$249,0000.11%
DG Capital Management, LLC 20,000$388,0000.08%
YorkBridge Wealth Partners, LLC 10,369$201,0000.05%
Ikarian Capital, LLC 26,632$517,0000.04%
Financial Advocates Investment Management 16,667$324,0000.02%
Janney Montgomery Scott LLC 99,323$1,929,0000.01%
Belvedere Trading LLC 16,177$302,0000.01%
FNY Investment Advisers, LLC 800$15,0000.01%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 17,200$334,0000.01%
View complete list of INMUNE BIO INC shareholders